Public Sector Pension Investment Board
PensionPosition in RNA — Atrium Therapeutics, Inc.
CIK 1396318
MONTREAL, A8
Position in RNA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$172,232
New position
Shares Held
12,882
first reported quarter
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Public Sector Pension Investment Board holds $340,768,011 across 30 Biotechnology names. RNA ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
73,300 | $53,527,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,037 | $40,205,867 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
92,286 | $23,839,319 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
331,852 | $22,609,076 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
210,280 | $22,163,512 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,177 | $18,387,177 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
487,257 | $16,186,677 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
366,674 | $14,751,295 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,232 | 12,882 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||